← Browse by Condition
Medical Condition

osteoarthritis hip

Total Trials
5
Recruiting Now
5
Trial Phases
Phase 3

ClinicalMetric tracks all active clinical trials for osteoarthritis hip sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — osteoarthritis hip Clinical Trials

How many clinical trials are currently recruiting for osteoarthritis hip?
ClinicalMetric currently tracks 5 actively recruiting clinical trials for osteoarthritis hip, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 5. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for osteoarthritis hip?
osteoarthritis hip research spans Phase 3 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a osteoarthritis hip clinical trial?
Eligibility criteria for osteoarthritis hip trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 3
1
Top Sponsors
JointResearch 1 trial
University of Colorado, Denver 1 trial
University of Turku 1 trial
Sint Maartenskliniek 1 trial
Isala 1 trial

Recruiting Clinical Trials

NCT04031820
Recruiting
Dual-mobility Cups Compared to Unipolar Cups on Dislocation and Cost-effectiveness After Primary Total Hip Arthroplasty.
Enrollment
1,100 pts
Location
Netherlands
Sponsor
JointResearch
View Trial →
NCT04137835
Recruiting
Non-invasive Evaluation of Upper and Lower Body Function With Showmotion
Enrollment
60 pts
Location
United States
Sponsor
University of Colorado, Denver
View Trial →
NCT05278520
Recruiting
Complex Molecular Etiology and Cellular Landscape of Hip Osteoarthritis
Enrollment
110 pts
Location
Finland
Sponsor
University of Turku
View Trial →
NCT06578182 Phase 3
Recruiting
The Effect of ColcHicine on the Incidence of Knee or Hip Replacements
Enrollment
1,410 pts
Location
Netherlands
Sponsor
Sint Maartenskliniek
View Trial →
NCT06342843
Recruiting
Direct Superior Approach Versus PosteroLateral Approach in Total Hip Arthroplasty (SPLAsH)
Enrollment
211 pts
Location
Netherlands
Sponsor
Isala
View Trial →

Related Conditions

osteoarthritis knee (2) total hip arthroplasty (1) osteoarthritis spine (1) rheumatoid arthritis (1)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology